10:02 AM EST - Amorfix Life Sciences Ltd. : announced that it has closed the first tranche of a non-brokered private placement pursuant to which a total of 800,000 units (Units) were issued at a price of $0.26 per unit for gross proceeds of $208,000. The total amount that can be raised under the Offering is $325,000. The Company intends to use the net proceeds of the Offering to continue the development of its research programs including its cancer therapeutic program, ProMIS™, its Alzheimer's disease and ALS diagnostic programs and for general corporate purposes. Amorfix Life Sciences Ltd.
shares T.AMF are trading unchanged at $0.38.
